1 min read
Interpace Biosciences Posts $10.4 Million in Q3 Revenue, $0.26 GAAP Loss Per Share
Revenue increased 18.7% from the year-earlier quarter.

Interpace Biosciences generated $10.4 million in revenue for the third quarter, an 18.7% increase from the same period a year earlier.
The company recorded a GAAP loss of $0.26 per share for the quarter.